MedTrace Logo

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)

NCT03843580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-02-18

No results posted yet for this study

Summary

Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways.

So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.

Conditions

  • Apnea, Postanesthetic
  • Desaturation of Blood
  • Apnea
  • Anesthesia
  • Larynx Disease
  • Pharynx; Anomaly

Interventions

DEVICE

optiflow

we use Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (thrive-optiflow) during general anesthesia for suspension laryngoscopy

Sponsors & Collaborators

  • Centre Francois Baclesse

    collaborator OTHER

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Eleonore Mulac-Vauclair · Centre Francois Baclesse

  • Pierre-Emmanuel Marsan · University Hospital, Caen

  • Kamga Herve · University Hospital, Caen

  • Boutros Mariam · University Hospital, Caen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2021-02-10
Completion
2022-02-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03843580 on ClinicalTrials.gov